UiPath Inc. (PATH)
For informational purposes only. Not financial advice.
UiPath Inc. (PATH) is a publicly traded company trading at $16.03 with a market cap of 8570906807. It holds a cautious AI score of 49/100 based on fundamental, technical, and sentiment analysis.
UiPath Inc. is a leading provider of robotic process automation (RPA) solutions, empowering organizations to streamline operations through advanced automation technologies. With a strong market presence and innovative platform, UiPath is well-positioned for growth in the expanding automation industry.
Company Overview
UiPath Inc. (PATH) stands at the forefront of the automation revolution, offering an innovative end-to-end platform that combines AI with RPA solutions, enabling organizations to optimize processes and drive efficiency across various sectors, including banking and healthcare.
Investment Thesis
Investing in UiPath Inc. (PATH) presents a compelling opportunity due to its strong market position and innovative automation solutions. With a market capitalization of $6.89 billion and a P/E ratio of 30.24, UiPath demonstrates solid profitability with a gross margin of 83.2% and a profit margin of 14.8%. The ongoing digital transformation across industries is driving demand for RPA solutions, and UiPath's comprehensive platform uniquely positions it to capitalize on this trend. The company is expected to benefit from increasing adoption of automation technologies, particularly in sectors like banking and healthcare, which are projected to grow significantly over the next few years. As organizations seek to enhance operational efficiency and reduce costs, UiPath's solutions will be critical in facilitating these objectives. With a focus on continuous innovation and expansion into new markets, UiPath is poised for sustained revenue growth, making it an attractive investment for those looking to tap into the automation wave.
Key Highlights
- Market Cap of $6.89B, reflecting strong investor confidence in automation solutions.
- P/E ratio of 30.24, indicating growth expectations in the software sector.
- Gross margin of 83.2%, showcasing operational efficiency and profitability.
- Profit margin of 14.8%, demonstrating effective cost management.
- Employee base of 3,868, indicating a robust operational capacity to support growth.
Competitors
Strengths
- Leading position in the RPA market with a comprehensive platform.
- High gross margins reflecting operational efficiency.
- Strong customer base across diverse industries.
Weaknesses
- Dependence on the North American market for revenue.
- Limited brand awareness in emerging markets.
- No dividend yield, which may deter income-focused investors.
Catalysts
- Upcoming: Expansion into emerging markets to capture new customers.
- Ongoing: Increased adoption of automation solutions in healthcare.
- Ongoing: Continuous product development to enhance platform capabilities.
Risks
- Potential: Intense competition from other automation providers.
- Ongoing: Dependence on the North American market for revenue.
- Potential: Economic downturns affecting customer budgets for software solutions.
Growth Opportunities
- Expansion into Emerging Markets: UiPath is actively exploring opportunities in emerging markets, particularly in Asia and Latin America, where the demand for automation solutions is on the rise. The global RPA market is expected to grow at a CAGR of 30% through 2027, providing a substantial opportunity for UiPath to capture new customers and increase market share in these regions.
- Increased Adoption in Healthcare: The healthcare sector is increasingly adopting automation technologies to streamline operations and improve patient care. UiPath's solutions can help healthcare organizations automate administrative tasks, leading to improved efficiency and reduced costs. With the healthcare automation market projected to grow significantly, UiPath is well-positioned to capitalize on this trend.
- Integration of AI and Machine Learning: UiPath's commitment to integrating advanced AI and machine learning capabilities into its platform enhances its value proposition. As organizations seek to leverage data-driven insights for automation, UiPath's innovative solutions can provide a competitive advantage, driving further adoption and revenue growth.
- Partnerships and Collaborations: UiPath is actively pursuing strategic partnerships with technology providers and consulting firms to enhance its service offerings and expand its reach. Collaborations can lead to new customer acquisitions and increased market penetration, particularly in industries such as finance and government.
- Focus on Product Development: Continuous investment in product development and innovation is a key growth driver for UiPath. By enhancing its platform's capabilities and introducing new features, the company can attract a broader customer base and retain existing clients, ultimately driving revenue growth.
Opportunities
- Rapid growth in the global RPA market.
- Increasing demand for automation in healthcare and finance.
- Potential for strategic partnerships to enhance offerings.
Threats
- Intense competition from established and emerging players.
- Rapid technological changes requiring continuous innovation.
- Economic downturns that may impact customer spending on software.
Competitive Advantages
- Strong brand recognition in the automation industry.
- Robust platform capabilities that integrate AI and RPA solutions.
- Established customer relationships across various sectors.
About
Founded in 2005 and headquartered in New York City, UiPath Inc. has evolved into a premier provider of robotic process automation (RPA) solutions. The company began its journey in Romania and has since expanded its operations globally, with significant market penetration in the United States, Romania, and Japan. UiPath's end-to-end automation platform is designed to help organizations build, manage, and govern automation processes effectively. The platform integrates artificial intelligence with tools for process discovery, automation development, and performance measurement, allowing users to identify and automate repetitive tasks seamlessly. One of the key differentiators of UiPath is its low-code development environment, which empowers users without coding experience to create both attended and unattended automations. This feature broadens the accessibility of automation within organizations and promotes widespread adoption. Furthermore, UiPath provides centralized management tools that enable enterprises to deploy and monitor automation solutions efficiently. The company serves a diverse range of industries, including banking, healthcare, financial services, and government entities, positioning itself as a critical partner in digital transformation efforts. With a robust support system that includes maintenance, training, and implementation services, UiPath ensures that its clients can maximize the value of their automation investments. As the demand for automation solutions continues to rise, UiPath is well-positioned to capture significant market share and drive future growth.
What They Do
- Provide an end-to-end automation platform for businesses.
- Offer robotic process automation (RPA) solutions to streamline operations.
- Combine artificial intelligence with automation tools for enhanced efficiency.
- Enable low-code development environments for users without coding experience.
- Facilitate the discovery and analysis of processes to automate.
- Support various industries, including banking, healthcare, and government.
Business Model
- Generate revenue through software licensing and subscription fees.
- Offer professional services, including training and implementation support.
- Provide maintenance and support services for ongoing customer needs.
Industry Context
The software infrastructure industry is experiencing significant growth, driven by the increasing demand for automation solutions across various sectors. The global RPA market is projected to reach $25 billion by 2027, growing at a CAGR of 30% from 2020. UiPath is well-positioned within this landscape, leveraging its advanced platform to meet the needs of organizations seeking to enhance efficiency and reduce operational costs. The competitive landscape includes peers such as BLSH, CFLT, CORZ, DBX, and DOX, each vying for market share in the rapidly evolving automation space. UiPath's comprehensive suite of solutions and strong brand recognition provide it with a competitive edge in this burgeoning market.
Key Customers
- Serve banking and financial services organizations seeking operational efficiency.
- Support healthcare providers aiming to improve patient care through automation.
- Partner with government entities to streamline administrative processes.
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $411M | $199M | $0.37 |
| Q3 2025 | $362M | $2M | $0.00 |
| Q2 2025 | $357M | -$23M | $-0.04 |
| Q1 2025 | $424M | $52M | $0.09 |
Source: Company filings
Chart & Info
Price Chart
UiPath Inc. (PATH) stock price: $16.03 (+0.15, +0.94%)
Why Bull
- •UiPath's recent insider buying suggests strong confidence from within, often a positive signal for future performance.
- •The community seems optimistic about UiPath's role in automation, viewing it as a key player in digital transformation.
- •Market perception sees UiPath benefiting from the increasing demand for AI-driven solutions, positioning it for sustained growth.
- •Bullish sentiment highlights UiPath's expanding customer base, indicating successful market penetration and adoption.
Why Bear
- •Some insiders are selling shares, which could indicate concerns about near-term growth or market conditions.
- •Community discussions reveal worries about UiPath's competition, with some believing rivals are gaining ground.
- •Market perception suggests UiPath's valuation is high, making it vulnerable to corrections if growth expectations aren't met.
- •Bearish views point to potential challenges in scaling operations and maintaining profitability amidst increasing competition.
Latest News
-
UiPath Strengthens its Position in the Global Automation Landscape
Zacks · Feb 20, 2026
-
Battle Royale: Nebius vs. UiPath. Only One Can Make You Rich.
Motley Fool · Feb 20, 2026
-
Could This $11 Stock Be Your Ticket to Millionaire Status?
Motley Fool · Feb 18, 2026
-
10 Information Technology Stocks Whale Activity In Today's Session
Benzinga · Feb 10, 2026
Technical Analysis
Rationale
AI-generated technical analysis for PATH including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss UiPath Inc. (PATH) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for PATH.
Make a Prediction
Set your price target for UiPath Inc. (PATH), choose a timeframe, and track your prediction accuracy.
Current price: $16.03
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PATH.
Price Targets
Wall Street price target analysis for PATH.
Insider Flow (30d)
MoonshotScore
Score Factors
-
Revenue Growth 4/100
Revenue grew only 9.3% YoY, suggesting the company is in a slower growth phase.
-
Gross Margin 10/100
Gross margin of 83.4% shows excellent pricing power and a strong competitive moat.
-
Operating Leverage 4/100
Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.
-
Cash Runway 5/100
Cash position data is currently unavailable for this company.
-
R&D Intensity 5/100
R&D spending data is currently unavailable for this company.
-
Insider Activity 6/100
No significant insider buying or selling recently, which is neutral for the stock outlook.
-
Short Interest 5/100
Float and volume data unavailable for liquidity analysis.
-
Price Momentum 0/100
No bullish technical signals detected. The stock lacks upward price momentum currently.
-
News Sentiment 5/100
No sentiment data available
What does this score mean?
The MoonshotScore rates PATH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
UiPath Strengthens its Position in the Global Automation Landscape
Battle Royale: Nebius vs. UiPath. Only One Can Make You Rich.
Could This $11 Stock Be Your Ticket to Millionaire Status?
10 Information Technology Stocks Whale Activity In Today's Session
Frequently Asked Questions
What does UiPath Inc. do?
UiPath Inc. provides an end-to-end automation platform that specializes in robotic process automation (RPA) solutions. The company offers a comprehensive suite of software tools that enable organizations to build, manage, and govern automation processes effectively. Their platform integrates artificial intelligence with low-code development environments, allowing users to automate repetitive tasks without prior coding knowledge. UiPath serves various industries, including banking, healthcare, and government, facilitating operational efficiency and digital transformation.
Is PATH stock a good buy?
UiPath Inc. (PATH) presents a compelling investment opportunity due to its strong market position and innovative automation solutions. With a market cap of $6.89 billion and a P/E ratio of 30.24, the company demonstrates solid profitability, backed by a gross margin of 83.2%. The ongoing digital transformation across industries is driving demand for RPA solutions, and UiPath's comprehensive platform is well-positioned to capitalize on this trend. Investors should consider the company's growth potential and strong operational metrics when evaluating the attractiveness of PATH stock.
What are the main risks for PATH?
UiPath Inc. faces several risks that investors should consider. The company operates in a highly competitive environment, with numerous established and emerging players vying for market share in the automation space. Additionally, UiPath's reliance on the North American market for revenue exposes it to economic fluctuations that could impact customer spending. Furthermore, rapid technological changes necessitate continuous innovation to remain relevant, which may pose challenges in maintaining competitive advantages.
Is PATH a good stock to buy?
Whether PATH is a suitable investment depends on your goals, risk tolerance, and time horizon. Evaluate UiPath Inc.'s revenue growth, profit margins, debt levels, and valuation relative to peers. This is not financial advice.
What is the PATH MoonshotScore?
The MoonshotScore rates PATH from 0 to 100 across growth potential, financial health, market momentum, and risk factors. Scores above 70 suggest strong potential, 50-70 moderate, and below 50 warrants caution. It is recalculated daily using the latest market data. This score is informational only.
How often is PATH data updated?
PATH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What do analysts say about PATH?
Analyst coverage for PATH includes consensus ratings (buy, hold, sell), 12-month price targets, and earnings estimates from major research firms. Key data points: consensus target price, number of covering analysts, recent upgrades or downgrades, and earnings beat/miss history. See the Analyst Consensus section on this page.
What are the risks of investing in PATH?
Risk categories for PATH include market risk, company-specific risk (management, competition), financial risk (debt, cash burn), and macroeconomic risk (rates, inflation). Beta above 1.0 indicates higher volatility than the S&P 500. Review the Risk Factors section on this page for details. All investments carry risk of loss.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.
- The analysis is based on available data as of February 2026 and may be subject to changes in market conditions.